SG39892G - 4,5-dihydro-oxazole derivatives,process for their preparation and their use - Google Patents

4,5-dihydro-oxazole derivatives,process for their preparation and their use

Info

Publication number
SG39892G
SG39892G SG398/92A SG39892A SG39892G SG 39892 G SG39892 G SG 39892G SG 398/92 A SG398/92 A SG 398/92A SG 39892 A SG39892 A SG 39892A SG 39892 G SG39892 G SG 39892G
Authority
SG
Singapore
Prior art keywords
preparation
denotes
dihydro
oxazole derivatives
hydrogen
Prior art date
Application number
SG398/92A
Other languages
English (en)
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of SG39892G publication Critical patent/SG39892G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
SG398/92A 1986-09-10 1992-04-11 4,5-dihydro-oxazole derivatives,process for their preparation and their use SG39892G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT243786 1986-09-10

Publications (1)

Publication Number Publication Date
SG39892G true SG39892G (en) 1992-10-02

Family

ID=3534337

Family Applications (1)

Application Number Title Priority Date Filing Date
SG398/92A SG39892G (en) 1986-09-10 1992-04-11 4,5-dihydro-oxazole derivatives,process for their preparation and their use

Country Status (21)

Country Link
US (1) US4818760A (sv)
EP (1) EP0261478B1 (sv)
JP (1) JPS6377878A (sv)
KR (1) KR880003941A (sv)
AT (1) ATE62908T1 (sv)
AU (1) AU596869B2 (sv)
CA (1) CA1256109A (sv)
CS (1) CS268191B2 (sv)
DD (1) DD262230A5 (sv)
DE (1) DE3769563D1 (sv)
DK (1) DK165322C (sv)
ES (1) ES2028838T3 (sv)
FI (1) FI89267C (sv)
GR (1) GR3001842T3 (sv)
HU (1) HU198059B (sv)
MY (1) MY102003A (sv)
NO (1) NO165195C (sv)
NZ (1) NZ221723A (sv)
SG (1) SG39892G (sv)
SU (1) SU1574177A3 (sv)
ZA (1) ZA876740B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002510293A (ja) * 1997-05-30 2002-04-02 ドクター・レディーズ・リサーチ・ファウンデーション 抗潰瘍剤として新規なベンゾイミダゾール誘導体、それらの製造方法、及びそれらを含有する薬学的組成物
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
PT1187601E (pt) 1999-06-07 2005-11-30 Altana Pharma Ag Nova forma de preparacao e a administracao compreendendo um inibidor da bomba de protoes instavel em meio acido
EP1534278A4 (en) * 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
RS52233B (en) * 2004-05-07 2012-10-31 Nycomed Gmbh THE PHARMACEUTICAL DOSAGE FORM CONTAINING GRANULES AND ITS PRODUCTION PROCEDURE
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) * 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
ES2032394T3 (es) * 1986-02-20 1993-02-16 Hoechst Aktiengesellschaft Procedimiento para preparar derivados de tienoimidazol sustituidos.

Also Published As

Publication number Publication date
CS268191B2 (en) 1990-03-14
ES2028838T3 (es) 1992-07-16
NO873722D0 (no) 1987-09-07
US4818760A (en) 1989-04-04
DK165322B (da) 1992-11-09
DK165322C (da) 1993-03-29
NO873722L (no) 1988-03-11
FI873892A (fi) 1988-03-11
NO165195C (no) 1991-01-09
ATE62908T1 (de) 1991-05-15
EP0261478A1 (de) 1988-03-30
AU7817087A (en) 1988-03-17
DK469687D0 (da) 1987-09-09
DE3769563D1 (de) 1991-05-29
ZA876740B (en) 1988-03-14
JPS6377878A (ja) 1988-04-08
HUT47288A (en) 1989-02-28
NO165195B (no) 1990-10-01
EP0261478B1 (de) 1991-04-24
AU596869B2 (en) 1990-05-17
CS649787A2 (en) 1989-05-12
NZ221723A (en) 1989-11-28
MY102003A (en) 1992-02-29
GR3001842T3 (en) 1992-11-23
KR880003941A (ko) 1988-05-31
DD262230A5 (de) 1988-11-23
DK469687A (da) 1988-03-11
HU198059B (en) 1989-07-28
FI89267B (fi) 1993-05-31
CA1256109A (en) 1989-06-20
FI873892A0 (fi) 1987-09-09
FI89267C (sv) 1993-09-10
SU1574177A3 (ru) 1990-06-23

Similar Documents

Publication Publication Date Title
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
SG39892G (en) 4,5-dihydro-oxazole derivatives,process for their preparation and their use
ES8706689A1 (es) Procedimiento para la obtencion de nuevos derivados del tieno (2,3-d) imidazol
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
EP0328913A3 (de) Neue basisch substituierte 5-Halogen-Thienoisothiazol-3(2H)-on-1,1-dioxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
AU579295B2 (en) New thiazole derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
SG43191G (en) Isoxazole derivatives, process for their preparation and pharmaceutical compositions containing them
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้